TTUHSC School of Medicine
HomeSchool of MedicineInternal MedicineFaculty




Profile for Nicholas D'Cunha, MD

Nicholas D'Cunha

Nicholas D'Cunha, MD

  • Associate Professor
  • Medical Director Bone Marrow Transplant Program
Office Phone: 806-743-3155
Email: Nicholas.DCunha@ttuhsc.edu
Mail Address: 3601 4th St Stop 9410
Lubbock TX 79430-9410

Positions:

  • Associate Professor, TTUHSC Lubbock, TX 2009-Present
  • Assistant Professor, TTUHSC Lubbock, TX 2003-2009
  • Clinical Experience Facilitator, TTUHSC Lubbock, TX 2007-2008
  • Community Physician Mentor, TTUHSC Lubbock, TX 2007-2008
  • Attending Physician, VA Medical Center White River Junction, New Hampshire 2002-2003

Admin Assignments:

  • Medical Director, Bone Marrow Transplant Program University Medical Center, Lubbock, TX 2003-Present
  • Assistant Professor, Department of Internal Medicine/ Div of Hem/Onc State University of New York, Syracuse, NY 1999-2002
  • Administrative Medical Officer, Topiwala National Medical College Topiwala National Medical College, Bombay, India 1984-1986

Post Doctoral Education:

  • Fellow: Fred Hutchinson Cancer Research Center, 1999
  • Fellow: Mount Sinai School of Medicine, 1995
  • Internship & Residency: Jersey City Medical Center, 1992
  • Externship: Jersey City Medical Center, 1989
  • House Officer & Registrar: Topiwala National Medical College & BYL Nair Charitable Hospital, 1984

Education:

  • MD: Topiwala National Medical College, 1982
  • MBBS: Topiwala National Medical College, 1980
  • BS: St. Xavier's College, 1974

Selected Publications:

  • Pandey, A & Radhi, S & Shrivastava, A & Arentz Ary, Suellen & Chiaramonte, R & Chiriva-Internati, Maurizio & Cobos, Everardo & D'Souza, M & D'Cunha, Nicholas & Grizzi, F & Hardwicke, Fred & Jenkins, Marjorie & Kast, W & Kurup, A & Nguyen, Diane & Platonova, N (2012) Cancer Testes Antigens in Breast Cancer: Biological Role, Regulation, and Therapeutic Applicability 31, 5, 302-320.
  • Radhi, S & Alalawi, Raed & Mirandola, L & Yu, Y & Pandey, A & D'Cunha, R & Saadeh, C & Nguyen, Diane & Hardwicke, Fred & D'Cunha, Nicholas & Tijani, Lukman & Jenkins, Marjorie & Jumper, Cynthia & Chiriva-Internati, Maurizio (2012) Novel Tumor Markers in Non-small Cell Lung Cancer Detected Both in Serology and Tissue E21105.
  • Schutt, Robert & Bumm, K & Mirandola, L & Bernardini, G & D'Cunha, Nicholas & Tijani, Lukman & Nguyen, Diane & Cordero, Joehassin & Jenkins, Marjorie & Cobos, Everardo & Chiriva-Internati, Maurizio February (2012) Immunological treatment options for locoregionally advanced head and neck squamous cell carcinoma. 31, 1, 22-42.
  • Jenkins, Marjorie & Chiriva-Internati, Maurizio & Mirandola, L & Tonroy, C & Tedjarati, S & Davis, N & D'Cunha, Nicholas & Tijani, Lukman & Hardwicke, Fred & Nguyen, Diane & Cobos, Everardo February (2012) Perspective for Prophylaxis and treatment of cervical cancer: an immunological approach 31, 1, 3-21.
  • Chiriva-Internati, Maurizio & Yu, Y & Mirandola, L & D'Cunha, Nicholas & Hardwicke, Fred & Cannon, MF & Cobos, Everardo & Kast, WM January (2012) Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer. 72, 1, 12-23.

Selected Presentations:

  • Compare The Outcome Of Patients With Hematological Malignancies Treated With Allogeneic Stem Cell Transplant In Patients Age Over 50 Conditioned With Reduce Intensity Regimens With Those Under 50 Conditioned With Standard Intensity Regimen In a Rural University Hospital American Society of Hematology, New Orleans, LA; December 2013.
  • American Association for Cancer Research, Washington, D.C.; April 2013.
  • Novel tumor markers in non-small cell lung cancer detected both in serology and tissue American Society of Clinical Oncology, Chicago, IL; June 2012.
  • AKAP-4: Cancer/Testis Antigen for Immunotherapy of Prostate Cancer Texas Tech University Health Sciences Center, Lubbock, TX; 2011.
  • New Antigens in Non-Small Cell Lung Cancer Detected Both in Serology and Tissue CPRIT, Austin, Texas; November 2011.

Selected Contracts and Grants:

  • A Study of V212 in the Prevention of Shingles in Patients Receiving an Autologous Bone Marrow or Stem Cell Transplant -
    Awarded by
    in the amount of $0
    Co-Investigator

  • A Phase 2 Open-label Study of MEDI-551 and Bendamustine vs Rituximab and Bendamustine in Adults With Relapsed or Refractory CLL -
    Awarded by Merck
    in the amount of $0
    Co-Investigator
    Research Related
  • A phase 2 Open-Label, Multi-center Clinical Study of the Safety and Efficacy of SNS 595 Injection in Patients 60 Years of Age or Older with Previously Untreated Acute Myeloid Leukemia -
    Awarded by Sunesis Pharmaceut
    in the amount of $0
    Principal
    Research Related
  • A phase 2 Study of Temozolomide (SCH 52365) in Subjects with Advanced Aero digestive Tract Cancers Selected for Methylation of 06 Methyl-Guanine-DNA Methyltransferase (MGMT) Promoter (P0473) -
    Awarded by
    in the amount of $0
    Principal
    Research Related
  • A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (> 4 cm) -IIIA Non-Small Cell Lung Cancer (NSCLC) -
    Awarded by Amgen
    in the amount of $0
    Co-Investigator
    Research Related

Selected Awards:

  • Outstanding Clerkship Educator, SOM, 2014.
  • Outstanding Clerkship Educator, SOM, 2013.
  • Outstanding Clerkship Educator, SOM, 2012.
  • Outstanding Clerkship Educator, SOM, 2011.
  • Outstanding Clerkship Educator, SOM, 2010.

Selected Scheduled Teaching:

  • ANEMIA TYPE AND TREATMENT -
  • BLEEDING DISORDER -
  • CANCER COMPLICATION INCLUDING COMPLICATION DUE TO CHEMOTHERAPY -
  • CLOTTING DISORDER AND HYPERCOAGUABLE STATE -
  • HEMATOLOGIC MALIGNANCIES -

Selected Non-Credit Instruction Taught:

  • Hematology/Oncology Morbidity and Mortality - 2013
  • Board Review in Oncology/Hematology - 2013
  • Malignancy of Unknown Primary Cancer - 2013
  • Thyroid Cancer: An Update - 2013
  • Board Review in Oncology/Hematology - 2013
Date last updated: 6/2/2014
©